Lupin rose 2.21% to Rs 2,393.80 after it has received tentative approval from the US Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Enzalutamide Tablets in ...

Lupin has received tentative approval from the Food and Drug Administration for enzalutamide tablets, 40 mg, 80 mg, 120 mg and 160 mg. Xtandi is used to treat certain types of pro ...

Dr. David Hung is pulling multiple financial levers to put Nuvation Bio on strong footing as it advances its oncology drugs.

By Michael Erman and Deena Beasley NEW YORK/SAN DIEGO, June 30 (Reuters) - President Donald Trump has promised to make U.S.

Why settle for puny yields when you can buy these monster dividend stocks?

Passive income is the paycheck that arrives whether you show up or not. Wages depend on a functioning employer, a healthy ...

By Michael Erman and Deena Beasley NEW YORK/SAN DIEGO, June 30 (Reuters) - President Donald Trump has promised to make U.S.

A 74-year-old man with an active lifestyle and no family history of prostate cancer presented with mild urinary hesitancy and ...

Lupin's shares rose as the USFDA granted tentative approval for its Enzalutamide tablets, offering new dosing options alongside bioequivalent alternatives to Xtandi.

Practice-changing perioperative therapy, chemo-free combo for CSPC, reducing cognitive eff ...

Overview on the use of androgen deprivation therapy (ADT) added to salvage radiation therapy (SRT) for prostate cancer patients with biochemical recurrence after prostatectomy. Th ...